Steve Grun of MNDL Bio

About this episode

Steve Grun discusses MNDL Bio's AI technology for improving protein production in biotech.

Steve Grun is the Co-Founder and CEO of MNDL Bio, an Israeli startup that uses AI to design better DNA sequences for making proteins—helping companies produce up to 20 times more protein than traditional methods. Their tech takes the guesswork out of gene design for biotech and pharma companies developing new drugs, enzymes, and other biological products. Avraham sat down with Steve to discuss why most biotech companies struggle to produce proteins at scale and how MNDL's AI platform fixes that, how he turned 15 years of academic research into a SaaS product, their $2 million pre-seed raise, tips for tech founders, where he sees the company in five years and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/ mndl-bio. Listen to all of the episodes at https://jmbdavis.com/podcast.

People in this episode

Host: Avraham

Guest: Steve Grun

Topics covered

• AI in biotech
• protein production
• startup funding
• gene design
• entrepreneurship

Keywords

• MNDL Bio
• AI
• DNA sequences
• protein production
• biotech startups
• SaaS product
• pre-seed funding

Mentioned in this episode

Organizations: MNDL Bio, JMB Davis Ben-David International IP Law Firm, biotech, pharma

Places: Israel

More episodes of Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs

• Racheli Ofir of Betalin Therapeutics · May 31, 2026 · 19 min
• Chen Neeman of Enqode · April 30, 2026 · 16 min
• Sharon Barak of Solutum · March 26, 2026 · 19 min
• Baruch Halpert of Electriq · February 26, 2026 · 24 min
• Dr. Hadas Ziso of EndoCure · January 29, 2026 · 20 min
• Hanan Brand head of the Startup Division Israel Innovation Authority · November 26, 2025 · 26 min